Skip to main content
Premium Trial:

Request an Annual Quote

EMBL-DKFZ Chemical Genomics Facility Partners with Tripos on Cheminformatics

NEW YORK, July 20 (GenomeWeb News) - A chemical genomics facility managed by the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) will use informatics software and services from Tripos to help analyze small-molecule screening data, the company said today.


The screening facility, based in Heidelberg, Germany, was launched in March and employs six full-time researchers.


Under the terms of the agreement, Tripos Discovery Research, Tripos' UK-based chemistry division, will provide the facility with a chemistry database and other chemistry processes to assist with hit finding, hit follow-up, and chemical optimization of candidate molecules.


Financial terms of the collaboration were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.